These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34204205)

  • 1. Preclinical In Vitro Studies with 3D Spheroids to Evaluate Cu(DDC)
    Hartwig F; Köll-Weber M; Süss R
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
    Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
    Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingomyelin-based PEGylation Cu (DDC)
    Liu H; Kong Y; Liu Z; Guo X; Yang B; Yin T; He H; Gou J; Zhang Y; Tang X
    Int J Pharm; 2022 Jun; 621():121788. PubMed ID: 35504431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
    Chen W; Yang W; Chen P; Huang Y; Li F
    ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer.
    Chang Y; Jiang J; Chen W; Yang W; Chen L; Chen P; Shen J; Qian S; Zhou T; Wu L; Hong L; Huang Y; Li F
    Appl Mater Today; 2020 Mar; 18():. PubMed ID: 34746366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activate the endogenous Cu
    Liang X; Li C; Yuan W; Ji M; Zhang J; Yan M; Lu Q; Gou J; Yin T; He H; Tang X; Zhang Y
    Int J Pharm; 2024 Mar; 652():123800. PubMed ID: 38218507
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kaul L; Abdo AI; Coenye T; Swift S; Zannettino A; Süss R; Richter K
    Biofilm; 2023 Dec; 5():100130. PubMed ID: 37274173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly Stable, Coordinated Polymeric Nanoparticles Loading Copper(II) Diethyldithiocarbamate for Combinational Chemo/Chemodynamic Therapy of Cancer.
    Peng X; Pan Q; Zhang B; Wan S; Li S; Luo K; Pu Y; He B
    Biomacromolecules; 2019 Jun; 20(6):2372-2383. PubMed ID: 31117352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of hepatocellular carcinoma with SP94 modified asymmetrical bilayer lipid-encapsulated Cu(DDC)
    Liu H; Kong Y; Liang X; Liu Z; Guo X; Yang B; Yin T; He H; Gou J; Zhang Y; Tang X
    Expert Opin Drug Deliv; 2023 Jan; 20(1):145-158. PubMed ID: 36462209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development.
    Wehbe M; Anantha M; Backstrom I; Leung A; Chen K; Malhotra A; Edwards K; Bally MB
    PLoS One; 2016; 11(4):e0153416. PubMed ID: 27055237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes.
    Marengo A; Forciniti S; Dando I; Dalla Pozza E; Stella B; Tsapis N; Yagoubi N; Fanelli G; Fattal E; Heeschen C; Palmieri M; Arpicco S
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):61-72. PubMed ID: 30267751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy.
    McMahon A; Chen W; Li F
    J Control Release; 2020 Mar; 319():352-359. PubMed ID: 31911155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein.
    Kang X; Wang J; Huang CH; Wibowo FS; Amin R; Chen P; Li F
    Nanomedicine; 2023 Jan; 47():102620. PubMed ID: 36265559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.
    Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP
    Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines.
    Said Suliman A; Khoder M; Tolaymat I; Webster M; Alany RG; Wang W; Elhissi A; Najlah M
    Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33435151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
    Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
    Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status.
    Wehbe M; Lo C; Leung AWY; Dragowska WH; Ryan GM; Bally MB
    Invest New Drugs; 2017 Dec; 35(6):682-690. PubMed ID: 28733701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitotane Nanocarriers for the Treatment of Adrenocortical Carcinoma: Evaluation of Albumin-Stabilized Nanoparticles and Liposomes in a Preclinical In Vitro Study with 3D Spheroids.
    Langer C; Köll-Weber M; Holzer M; Hantel C; Süss R
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of diethyldithiocarbamate and copper ions is active against
    Kaul L; Abdo AI; Coenye T; Krom BP; Hoogenkamp MA; Zannettino ACW; Süss R; Richter K
    Front Microbiol; 2022; 13():999893. PubMed ID: 36160243
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.
    Zhang T; Kephart J; Bronson E; Anand M; Daly C; Spasojevic I; Bakthavatsalam S; Franz K; Berg H; Karachaliou GS; James OG; Howard L; Halabi S; Harrison MR; Armstrong AJ; George DJ
    Prostate; 2022 May; 82(7):858-866. PubMed ID: 35286730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.